psychedelics investing Optimi Health Announces Closing of Oversubscribed US$15 Million Public Offering
psychedelics investing Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq Uplisting
psychedelics investing Optimi Health Launches Ibogaine Initiative as U.S. Executive Order Signals Pathway for Psychedelic Drug Products
psychedelics investing Optimi Health Announces Proposed Nasdaq Listing and U.S. Underwritten Public Offering
psychedelics investing Optimi Health Reports Early Clinical Rollout of Natural Psilocybin Capsules for Treatment-Resistant Depression in Australia
psychedelics investing Optimi Health Completes Psilocybin Export to Australia for Treatment Resistant Depression
psychedelics investing Optimi Health Reports First MDMA-Assisted Treatments of 2026 are Underway Across an Expanded Network of Australian Clinics
psychedelics investing Optimi Health Completes MDMA Export for PTSD Treatment Under Australia's Authorised Prescriber Scheme
psychedelics investing Optimi Health to Present at the Sidoti Micro-Cap Conference on January 21-22, 2026
NevGold Announces Up To 53.7% Antimony, And Fourteen Samples Over 2% Antimony, From Surface Sampling On Pre-Strip Dump
TomaGold Completes Extension Drilling Program at Berrigan Mine and Launches Major Prospecting and Geophysical Survey Campaign Across its Chibougamau Properties
